Dividend Aristocrat Becton Dickinson and Company (BDX) will raise its quarterly dividend by 4.6 percent to 91 cents per share in 2022. This marks 51 years in a row of dividend increases by the medical devices maker. The new dividend yield for BDX is 1.6% at a stock price of $222.

Becton, Dickinson and Company (BD) is a global medical technology company engaged in the development, manufacture and sale of a broad range of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, physicians, life science researchers, clinical laboratories, the pharmaceutical industry and the general public. BD’s operations consist of three worldwide business segments: BD Medical, BD Life Sciences and BD Interventional. Becton, Dickinson and Company was incorporated under the laws of the State of New Jersey in November 1906, as successor to a New York business started in 1897.